Which heart failure patients benefit the most from long term digoxin therapy?

被引：0
|
作者：
Yusuf, S
Garg, R
Smith, T
Dagenais, G
Montague, T
Arnold, M
Davies, R
Teo, KK
Bourassa, M
Collins, J
Williford, W
Gorlin, R
机构：
[1] MCMASTER UNIV,HAMILTON,ON,CANADA
[2] NHLBI,BETHESDA,MD 20892
[3] HARVARD UNIV,SCH MED,BOSTON,MA
[4] UNIV MONTREAL,MONTREAL,PQ,CANADA
来源：
CIRCULATION | 1996年 / 94卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [41] The effects of Digoxin use on long-term prognosis in patients with heart failure with reduced ejection fraction
    Ozyildirim, S.
    Barman, H. A.
    Dogan, O.
    Atici, A.
    Mirzayev, K.
    Ebeoglu, A. O.
    Yumuk, M. T.
    Ikitimur, B.
    Dogan, S. M.
    Enar, R.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (15) : 7226 - 7234
  • [42] Benefit of Cardiac Resynchronization Therapy in Patients with Heart Failure
    Calborean, Veronica
    Ciobanu, Daniela
    Mirea, Sorin Cecil
    Galceava, Oana
    Gheorman, Victor
    Padureanu, Vlad
    Fortofoiu, Catalin Mircea
    Fortofoiu, Maria
    Mita, Adrian
    Dinescip, Sorin Nicolae
    Miscocl, Silvia Alina
    Dinescu, Venera Cristina
    [J]. REVISTA DE CHIMIE, 2018, 69 (09): : 2461 - 2464
  • [43] HUMAN MYOCARDIUM AND PLASMA DIGOXIN CONCENTRATION IN PATIENTS ON LONG-TERM DIGOXIN THERAPY
    LICHEY, J
    HAVESTATT, C
    WEINMANN, J
    HASFORD, J
    RIETBROCK, N
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1978, 16 (10): : 460 - 462
  • [44] Long term outcome of heart failure patients disqualified from heart transplantation
    Polaska, Paula
    Jerzak-Wodzynska, Grazyna
    Smigielski, Witold
    Gajda, Janusz
    Rozentryt, Piotr
    Korewicki, Jerzy
    Sobieszczanska-Malek, Malgorzata
    Zielinski, Tomasz
    Rywik, Tomasz M.
    [J]. ACTA CARDIOLOGICA, 2021, 76 (05) : 525 - 533
  • [45] Impact of digoxin on risk of death in heart failure patients treated with β-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry
    Migaj, Jacek
    Kaluzna-Oleksy, Marta
    Nessler, Jadwiga
    Opolski, Grzegorz
    Crespo-Leiro, Marisa G.
    Maggioni, Aldo P.
    Grajek, Stefan
    Ponikowski, Piotr
    Drozdz, Jaroslaw
    Straburzynska-Migaj, Ewa
    [J]. KARDIOLOGIA POLSKA, 2018, 76 (07) : 1064 - 1072
  • [46] Which patients with ischaemic heart disease could benefit from cell replacement therapy?
    Lipiecki, Janusz
    Durel, Nicolas
    Ponsonnaille, Jean
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0H) : H3 - H7
  • [47] The identification of heart failure patients prone to benefit from cardiac resynchronisation therapy
    Pitzalis, M. V.
    Iacoviello, M.
    Romito, R.
    De Tommasi, E.
    Guida, P.
    Luzzi, G.
    [J]. ADVANCES IN HEART DISEASE, 2006, : 547 - +
  • [48] LONG-TERM DIGOXIN THERAPY
    GOLDSMITH, SR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (03) : 838 - 838
  • [49] Effect of digoxin on clinical outcomes in patients on contemporary heart failure therapy
    Dhaliwal, Amandeep S.
    Carabello, Blaise
    Bredikis, Audrius
    Habib, Gabriel
    Ramasubbu, Kumudha
    Bozkurt, Biykem
    [J]. JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S100 - S100
  • [50] Does digoxin therapy affect outcome in patients with diastolic heart failure?
    Brutsaert, Dirk L.
    [J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (02): : 70 - 71
12345